The allosteric modulator 1-(4-chlorophenyl)-3-(3-(6-(pyrrolidin-1-yl)pyridin-2-yl)phenyl)urea (PSNCBAM-1, 2) bound the cannabinoid receptor 1 (CB1) and antagonized G protein coupling. This compound demonstrated potent anorectic effects similar to the CB1 antagonist rimonabant that once was marketed for the treatment of obesity, suggesting a new chemical entity for the discovery of antiobesity drugs. To increase structural diversity of this class of CB1 ligands, we designed and synthesized two classes of novel analogues, in which the pyridine ring of 2 was replaced by a pyrimidine ring. These positively modulate the binding of the CB1 orthosteric agonist CP55,940 while exhibiting an antagonism of G-protein coupling activity. Interestingly, compounds 7d and 8d demonstrated ERK1/2 phosphorylation mediated via β-arrestin unlike the orthosteric CP55,940 that does so in a G protein-dependent manner. These can serve as new lead compounds for the future development of CB1 allosteric modulators that show biased agonism and potentially antiobesity behavior via a new mechanism.
The allosteric modulator 1-(4-chlorophenyl)-3-(3-(6-(pyrrolidin-1-yl)pyridin-2-yl)phenyl)urea (n class="Chemical">PSNCBAM-1, 2) bound the cannabinoid receptor 1 (CB1) and antagonized G protein coupling. This compound demonstrated potent anorectic effects similar to the CB1 antagonist rimonabant that once was marketed for the treatment of obesity, suggesting a new chemical entity for the discovery of antiobesity drugs. To increase structural diversity of this class of CB1 ligands, we designed and synthesized two classes of novel analogues, in which the pyridine ring of 2 was replaced by a pyrimidine ring. These positively modulate the binding of the CB1 orthosteric agonist CP55,940 while exhibiting an antagonism of G-protein coupling activity. Interestingly, compounds 7d and 8d demonstrated ERK1/2 phosphorylation mediated via β-arrestin unlike the orthosteric CP55,940 that does so in a G protein-dependent manner. These can serve as new lead compounds for the future development of CB1 allosteric modulators that show biased agonism and potentially antiobesity behavior via a new mechanism.
Authors: Francis S Willard; Denise Wootten; Aaron D Showalter; Emilia E Savage; James Ficorilli; Thomas B Farb; Krister Bokvist; Jorge Alsina-Fernandez; Sebastian G B Furness; Arthur Christopoulos; Patrick M Sexton; Kyle W Sloop Journal: Mol Pharmacol Date: 2012-08-28 Impact factor: 4.436
Authors: Matthew D Lebar; Kristopher N Hahn; Tina Mutka; Patrick Maignan; James B McClintock; Charles D Amsler; Alberto van Olphen; Dennis E Kyle; Bill J Baker Journal: Bioorg Med Chem Date: 2011-08-22 Impact factor: 3.641
Authors: J G Horswill; U Bali; S Shaaban; J F Keily; P Jeevaratnam; A J Babbs; C Reynet; P Wong Kai In Journal: Br J Pharmacol Date: 2007-06-25 Impact factor: 8.739
Authors: Fabricio A Pamplona; Juliano Ferreira; Octávio Menezes de Lima; Filipe Silveira Duarte; Allisson Freire Bento; Stefânia Forner; Jardel G Villarinho; Luigi Bellocchio; Luigi Bellochio; Carsten T Wotjak; Raissa Lerner; Krisztina Monory; Beat Lutz; Claudio Canetti; Isabelle Matias; João Batista Calixto; Giovanni Marsicano; Marilia Z P Guimarães; Reinaldo N Takahashi Journal: Proc Natl Acad Sci U S A Date: 2012-11-12 Impact factor: 11.205
Authors: Elizabeth A Cairns; Anna-Maria Szczesniak; Alex J Straiker; Pushkar M Kulkarni; Roger G Pertwee; Ganesh A Thakur; William H Baldridge; Melanie E M Kelly Journal: J Ocul Pharmacol Ther Date: 2017-07-18 Impact factor: 2.671
Authors: Caitlin A D Jagla; Caitlin E Scott; Yaliang Tang; Changjiang Qiao; Gabriel E Mateo-Semidey; Guillermo A Yudowski; Dai Lu; Debra A Kendall Journal: Mol Pharmacol Date: 2018-10-15 Impact factor: 4.436
Authors: Thuy Nguyen; Nadezhda German; Ann M Decker; Tiffany L Langston; Thomas F Gamage; Charlotte E Farquhar; Jun-Xu Li; Jenny L Wiley; Brian F Thomas; Yanan Zhang Journal: J Med Chem Date: 2017-08-18 Impact factor: 7.446
Authors: Thuy Nguyen; Thomas F Gamage; Ann M Decker; David B Finlay; Tiffany L Langston; Daniel Barrus; Michelle Glass; Danni L Harris; Yanan Zhang Journal: Bioorg Med Chem Date: 2021-05-12 Impact factor: 3.461